Healthcare provider profile · identity verified

Christopher John Sipple, MD

Family Practice · BRILLION, WI · NPI 1093799686

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	510	121
Losartan Potassium	Losartan Potassium	328	78
Levothyroxine Sodium	Levothyroxine Sodium	319	64
Lisinopril	Lisinopril	287	75
Metformin Hcl	Metformin Hcl	270	69
Pantoprazole Sodium	Pantoprazole Sodium	254	57
Amlodipine Besylate	Amlodipine Besylate	249	65
Rosuvastatin Calcium	Rosuvastatin Calcium	241	58
Eliquis	Apixaban	232	34
Gabapentin	Gabapentin	226	44
Omeprazole	Omeprazole	226	53
Metoprolol Succinate	Metoprolol Succinate	196	46
Furosemide	Furosemide	185	43
Clonazepam	Clonazepam	183	24
Sertraline Hcl	Sertraline Hcl	169	43
Metoprolol Tartrate	Metoprolol Tartrate	167	44
Escitalopram Oxalate	Escitalopram Oxalate	164	33
Glipizide Er	Glipizide	156	37
Simvastatin	Simvastatin	151	39
Allopurinol	Allopurinol	149	32
Tamsulosin Hcl	Tamsulosin Hcl	146	31
Albuterol Sulfate Hfa	Albuterol Sulfate	145	39
Hydrochlorothiazide	Hydrochlorothiazide	145	44
Warfarin Sodium	Warfarin Sodium	134	34
Glipizide	Glipizide	125	27
Prednisone	Prednisone	125	72
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	117	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	116	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	19
Pioglitazone Hcl	Pioglitazone Hcl	106	23
Bupropion Xl	Bupropion Hcl	103	18
Potassium Chloride	Potassium Chloride	100	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	20
Ozempic	Semaglutide	88	12
Atenolol	Atenolol	87	23
Carvedilol	Carvedilol	86	24
Celecoxib	Celecoxib	85	15
Venlafaxine Hcl Er	Venlafaxine Hcl	85	15
Duloxetine Hcl	Duloxetine Hcl	82	18
Trazodone Hcl	Trazodone Hcl	80	18
Clopidogrel	Clopidogrel Bisulfate	78	23
Cephalexin	Cephalexin	76	55
Fluticasone Propionate	Fluticasone Propionate	74	33
Myrbetriq	Mirabegron	67	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	65	suppressed
Donepezil Hcl	Donepezil Hcl	64	suppressed
Azithromycin	Azithromycin	63	56
Synthroid	Levothyroxine Sodium	61	12
Finasteride	Finasteride	60	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	60	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	15
Memantine Hcl	Memantine Hcl	60	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	55	15
Lorazepam	Lorazepam	53	13
Jardiance	Empagliflozin	52	suppressed
Tizanidine Hcl	Tizanidine Hcl	52	suppressed
Cefdinir	Cefdinir	48	35
Triamcinolone Acetonide	Triamcinolone Acetonide	48	35
Bumetanide	Bumetanide	47	13
Xarelto	Rivaroxaban	47	suppressed
Spiriva Handihaler	Tiotropium Bromide	45	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	11
Amoxicillin	Amoxicillin	40	21
Ezetimibe	Ezetimibe	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Chlorthalidone	Chlorthalidone	39	suppressed
Alprazolam	Alprazolam	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	25
Diclofenac Sodium	Diclofenac Sodium	37	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Meloxicam	Meloxicam	35	16
Silodosin	Silodosin	35	suppressed
Baclofen	Baclofen	33	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	33	18
Spironolactone	Spironolactone	33	suppressed
Digoxin	Digoxin	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	11
Montelukast Sodium	Montelukast Sodium	32	suppressed
Temazepam	Temazepam	31	suppressed
Metformin Hcl Er	Metformin Hcl	30	11
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	12
Terazosin Hcl	Terazosin Hcl	29	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	28	suppressed
Levofloxacin	Levofloxacin	27	25
Methylprednisolone	Methylprednisolone	27	12
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Topiramate	Topiramate	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Methimazole	Methimazole	23	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	15
Propranolol Hcl	Propranolol Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	12
Gemfibrozil	Gemfibrozil	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Oxycontin	Oxycodone Hcl	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Estradiol	Estradiol	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Fluconazole	Fluconazole	13	11
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Risperidone	Risperidone	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	11	suppressed
Lactulose	Lactulose	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error